On September 3, 2026 Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, reported that management plans to participate in the following upcoming investor conferences:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Global Healthcare Conference (September 9-11 in New York City)

Format: Fireside Chat and 1×1 Investor Meetings
Date/Time: Thursday, September 10, 2026, from 2:45-3:15 pm ET

H.C. Wainwright 28th Annual Global Investment Conference (September 14-16 in New York City)

Format: Fireside Chat and 1×1 Investor Meetings
Date/Time: Monday, September 14, 2026, from 5:00-5:30 pm ET

The fireside chats will be webcast live and archived in the Investor Relations section of Immuneering’s website at Events & Presentations | Immuneering Corporation.

(Press release, Immuneering, SEP 3, 2026, View Source [SID1234670582])